Literature DB >> 23890524

Synthesis and characterization of time-resolved fluorescence probes for evaluation of competitive binding to melanocortin receptors.

Ramesh Alleti1, Josef Vagner, Dilani Chathurika Dehigaspitiya, Valerie E Moberg, N G R D Elshan, Narges K Tafreshi, Nabila Brabez, Craig S Weber, Ronald M Lynch, Victor J Hruby, Robert J Gillies, David L Morse, Eugene A Mash.   

Abstract

Probes for use in time-resolved fluorescence competitive binding assays at melanocortin receptors based on the parental ligands MSH(4), MSH(7), and NDP-α-MSH were prepared by solid phase synthesis methods, purified, and characterized. The saturation binding of these probes was studied using HEK-293 cells engineered to overexpress the human melanocortin 4 receptor (hMC4R) as well as the human cholecystokinin 2 receptor (hCCK2R). The ratios of non-specific binding to total binding approached unity at high concentrations for each probe. At low probe concentrations, receptor-mediated binding and uptake was discernable, and so probe concentrations were kept as low as possible in determining Kd values. The Eu-DTPA-PEGO-MSH(4) probe exhibited low specific binding relative to non-specific binding, even at low nanomolar concentrations, and was deemed unsuitable for use in competition binding assays. The Eu-DTPA-PEGO probes based on MSH(7) and NDP-α-MSH exhibited Kd values of 27±3.9nM and 4.2±0.48nM, respectively, for binding with hMC4R. These probes were employed in competitive binding assays to characterize the interactions of hMC4R with monovalent and divalent MSH(4), MSH(7), and NDP-α-MSH constructs derived from squalene. Results from assays with both probes reflected only statistical enhancements, suggesting improper ligand spacing on the squalene scaffold for the divalent constructs. The Ki values from competitive binding assays that employed the MSH(7)-based probe were generally lower than the Ki values obtained when the probe based on NDP-α-MSH was employed, which is consistent with the greater potency of the latter probe. The probe based on MSH(7) was also competed with monovalent, divalent, and trivalent MSH(4) constructs that previously demonstrated multivalent binding in competitive binding assays against a variant of the probe based on NDP-α-MSH. Results from these assays confirm multivalent binding, but suggest a more modest increase in avidity for these MSH(4) constructs than was previously reported.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  1-(9H-fluoren-9-yl)-3,19-dioxo-2,8,11,14,21-pentaoxa-4,18-diazatricosan-23-oic acid; 1-hydroxybenzotriazole; 19-amino-5-oxo-3,10,13,16-tetraoxa-6-azanonadecan-1-oic acid; 6-chloro-1-hydroxybenzotriazole; 9-fluorenylmethyoxycarbonyl; Ac-Ser-Tyr-Ser-Nle-Glu-His-DPhe-Arg-Trp-Gly-Lys-Pro-Val-NH(2); BSA; Cl-HOBt; Competition binding assays; CuAAC; DCM; DIC; DIEA; DMEM; DMF; DMSO; DTPA; Dulbecco’s Modified Eagle Medium; ESI MS; FT-ICR MS; Fluorescent probes; Fmoc; Fmoc-PEGO; Fourier transform ion cyclotron resonance mass spectrometry; HOBt; HRMS; His-DPhe-Arg-Trp; IC(50); MEM; MSH(4); MSH(7); Melanocortin 4 receptor; Minimum Essential Medium; N,N-dimethylformamide; NDP-α-MSH; PEGO; Saturation binding assays; Ser-Nle-Glu-His-DPhe-Arg-Trp; TBTA; TEAA; TFA; THF; TLC; TRF; Time-resolved fluorescence; bovine serum albumin; copper(I)-catalyzed azide-alkyne cycloaddition; dichloromethane; diethylenetriaminepentaacetic acid; diisopropyl carbodiimide; diisopropylethylamine; dimethyl sulfoxide; electrospray ionization mass spectrometry; hMC4R; half maximal inhibitory concentration; high resolution mass spectroscopy; human melanocortin 4 receptor; tetrahydrofuran; thin-layer chromatography; time-resolved fluorescence; triethylammonium acetate; trifluoroacetic acid; tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine

Mesh:

Substances:

Year:  2013        PMID: 23890524      PMCID: PMC3773999          DOI: 10.1016/j.bmc.2013.06.052

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  23 in total

Review 1.  International Union of Pharmacology. XXI. Structure, distribution, and functions of cholecystokinin receptors.

Authors:  F Noble; S A Wank; J N Crawley; J Bradwejn; K B Seroogy; M Hamon; B P Roques
Journal:  Pharmacol Rev       Date:  1999-12       Impact factor: 25.468

2.  Cell-specific targeting by heterobivalent ligands.

Authors:  Jatinder S Josan; Heather L Handl; Rajesh Sankaranarayanan; Liping Xu; Ronald M Lynch; Josef Vagner; Eugene A Mash; Victor J Hruby; Robert J Gillies
Journal:  Bioconjug Chem       Date:  2011-06-16       Impact factor: 4.774

3.  A sucrose-derived scaffold for multimerization of bioactive peptides.

Authors:  Venkataramanarao Rao; Ramesh Alleti; Liping Xu; Narges K Tafreshi; David L Morse; Robert J Gillies; Eugene A Mash
Journal:  Bioorg Med Chem       Date:  2011-08-27       Impact factor: 3.641

4.  Design, synthesis, and biological studies of efficient multivalent melanotropin ligands: tools toward melanoma diagnosis and treatment.

Authors:  Nabila Brabez; Ronald M Lynch; Liping Xu; Robert J Gillies; Gerard Chassaing; Solange Lavielle; Victor J Hruby
Journal:  J Med Chem       Date:  2011-10-03       Impact factor: 7.446

5.  A solanesol-derived scaffold for multimerization of bioactive peptides.

Authors:  Ramesh Alleti; Venkataramanarao Rao; Liping Xu; Robert J Gillies; Eugene A Mash
Journal:  J Org Chem       Date:  2010-09-03       Impact factor: 4.354

6.  Synthesis and characterization of a Eu-DTPA-PEGO-MSH(4) derivative for evaluation of binding of multivalent molecules to melanocortin receptors.

Authors:  Liping Xu; Josef Vagner; Ramesh Alleti; Venkataramanarao Rao; Bhumasamudram Jagadish; David L Morse; Victor J Hruby; Robert J Gillies; Eugene A Mash
Journal:  Bioorg Med Chem Lett       Date:  2010-03-04       Impact factor: 2.823

Review 7.  Copper-catalyzed azide-alkyne cycloaddition (CuAAC) and beyond: new reactivity of copper(I) acetylides.

Authors:  Jason E Hein; Valery V Fokin
Journal:  Chem Soc Rev       Date:  2010-03-04       Impact factor: 54.564

8.  Lanthanide-based time-resolved fluorescence of in cyto ligand-receptor interactions.

Authors:  Heather L Handl; Josef Vagner; Henry I Yamamura; Victor J Hruby; Robert J Gillies
Journal:  Anal Biochem       Date:  2004-07-15       Impact factor: 3.365

9.  Modeling and docking of the three-dimensional structure of the human melanocortin 4 receptor.

Authors:  Xiaonan Yang; Zhuorui Wang; Wei Dong; Lunjiang Ling; Huanming Yang; Runsheng Chen
Journal:  J Protein Chem       Date:  2003-05

10.  Optimization of time-resolved fluorescence assay for detection of europium-tetraazacyclododecyltetraacetic acid-labeled ligand-receptor interactions.

Authors:  Channa R De Silva; Josef Vagner; Ronald Lynch; Robert J Gillies; Victor J Hruby
Journal:  Anal Biochem       Date:  2009-10-21       Impact factor: 3.365

View more
  7 in total

Review 1.  Bench-top to clinical therapies: A review of melanocortin ligands from 1954 to 2016.

Authors:  Mark D Ericson; Cody J Lensing; Katlyn A Fleming; Katherine N Schlasner; Skye R Doering; Carrie Haskell-Luevano
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-03-29       Impact factor: 5.187

2.  Synthesis and bioactivity of MSH4 oligomers prepared by an A2 + B2 strategy.

Authors:  Dilani Chathurika Dehigaspitiya; Suryakiran Navath; Craig S Weber; Ronald M Lynch; Eugene A Mash
Journal:  Tetrahedron Lett       Date:  2015-06-03       Impact factor: 2.415

3.  A Direct in Vivo Comparison of the Melanocortin Monovalent Agonist Ac-His-DPhe-Arg-Trp-NH2 versus the Bivalent Agonist Ac-His-DPhe-Arg-Trp-PEDG20-His-DPhe-Arg-Trp-NH2: A Bivalent Advantage.

Authors:  Cody J Lensing; Danielle N Adank; Stacey L Wilber; Katie T Freeman; Sathya M Schnell; Robert C Speth; Adam T Zarth; Carrie Haskell-Luevano
Journal:  ACS Chem Neurosci       Date:  2017-02-16       Impact factor: 4.418

4.  Trigonal scaffolds for multivalent targeting of melanocortin receptors.

Authors:  N G R Dayan Elshan; Thanuja Jayasundera; Bobbi L Anglin; Craig S Weber; Ronald M Lynch; Eugene A Mash
Journal:  Org Biomol Chem       Date:  2015-02-14       Impact factor: 3.876

5.  Development of a time-resolved fluorescence probe for evaluation of competitive binding to the cholecystokinin 2 receptor.

Authors:  N G R Dayan Elshan; Thanuja Jayasundera; Craig S Weber; Ronald M Lynch; Eugene A Mash
Journal:  Bioorg Med Chem       Date:  2015-02-26       Impact factor: 3.641

6.  An in Vitro and in Vivo Investigation of Bivalent Ligands That Display Preferential Binding and Functional Activity for Different Melanocortin Receptor Homodimers.

Authors:  Cody J Lensing; Katie T Freeman; Sathya M Schnell; Danielle N Adank; Robert C Speth; Carrie Haskell-Luevano
Journal:  J Med Chem       Date:  2016-03-29       Impact factor: 7.446

7.  Spectrophotometric determination and removal of unchelated europium ions from solutions containing Eu-diethylenetriaminepentaacetic acid chelate-peptide conjugates.

Authors:  N G R Dayan Elshan; Renata Patek; Josef Vagner; Eugene A Mash
Journal:  Anal Biochem       Date:  2014-07-21       Impact factor: 3.365

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.